Presenilin-2: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 28: | Line 28: | ||
[[Category:Genes on human chromosome 1]] | [[Category:Genes on human chromosome 1]] | ||
[[Category:Alzheimer's disease research]] | [[Category:Alzheimer's disease research]] | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 23:42, 17 March 2025
Presenilin-2[edit]
Presenilin-2 is a protein that in humans is encoded by the PSEN2 gene. It is a member of the presenilin family, which also includes Presenilin-1. Presenilins are integral membrane proteins that are primarily located in the endoplasmic reticulum and Golgi apparatus.
Function[edit]
Presenilin-2 is involved in the processing of the amyloid precursor protein (APP) and is a component of the gamma-secretase complex. This complex is responsible for the proteolytic cleavage of APP, which is a critical step in the production of amyloid-beta peptides. These peptides can aggregate to form plaques, which are a hallmark of Alzheimer's disease.
Gene[edit]
The PSEN2 gene is located on chromosome 1 in humans. It is one of the genes associated with familial Alzheimer's disease, a hereditary form of the disease. Mutations in PSEN2 can lead to altered gamma-secretase activity and increased production of amyloid-beta.
Clinical Significance[edit]
Mutations in the PSEN2 gene have been linked to early-onset familial Alzheimer's disease. These mutations are less common than those in the PSEN1 gene but can still have significant effects on the development of the disease. Research into presenilin-2 and its role in Alzheimer's disease continues to be an important area of study.
Related Proteins[edit]
Presenilin-2 is closely related to Presenilin-1, and both proteins share similar functions and structures. They are both components of the gamma-secretase complex and play roles in the cleavage of various type I transmembrane proteins.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which presenilin-2 mutations contribute to Alzheimer's disease. Studies are also exploring potential therapeutic targets within the gamma-secretase complex to modulate its activity and reduce amyloid-beta production.
See Also[edit]
